Related Experiment Video
Updated: Feb 25, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Autocrine mechanisms of cancer chemoresistance
Giovanna Butera1, Raffaella Pacchiana1, Massimo Donadelli1
1Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Verona, Italy.
Abstract:
An ever-increasing number of studies highlight the role of cancer secretome in the modification of tumour microenvironment and in the acquisition of cancer cell resistance to therapeutic drugs. The knowledge of the mechanisms underlying the relationship between cancer cell-secreted factors and chemoresistance is becoming fundamental for the identification of novel anticancer therapeutic strategies overcoming drug resistance and novel prognostic secreted biomarkers. In this review, we summarize the novel findings concerning the regulation of secreted molecules by cancer cells compromising drug sensitivity. In particular, we highlight data from available literature describing the involvement of cancer cell-secreted molecules determining chemoresistance in an autocrine manner, including: i) growth factors; ii) glycoproteins; iii) inflammatory cytokines; iv) enzymes and chaperones; and v) tumor-derived exosomes.
Insights
Cancer cells secrete factors that promote drug resistance by altering the tumor microenvironment. Understanding these secreted molecules is key to developing new cancer therapies and biomarkers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The cancer secretome significantly influences the tumor microenvironment.
- Cancer cell-secreted factors contribute to therapeutic drug resistance.
- Understanding these mechanisms is crucial for advancing cancer treatment.
Purpose of the Study:
- To review novel findings on secreted molecules regulating cancer cell drug sensitivity.
- To highlight cancer cell-secreted factors involved in chemoresistance.
- To identify potential therapeutic targets and prognostic biomarkers.
Main Methods:
- Literature review of recent studies on cancer secretome and chemoresistance.
- Analysis of autocrine signaling pathways mediated by secreted molecules.
- Categorization of secreted factors influencing drug sensitivity.
Main Results:
- Cancer cells secrete various factors, including growth factors, glycoproteins, and cytokines, that induce chemoresistance.
- Enzymes, chaperones, and tumor-derived exosomes also play a role in mediating drug resistance.
- Autocrine signaling by these secreted molecules is a significant mechanism of chemoresistance.
Conclusions:
- Secreted molecules from cancer cells are critical regulators of chemoresistance.
- Targeting these secreted factors offers potential for novel anticancer strategies.
- Secreted biomarkers hold promise for prognosis and therapeutic monitoring.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chemotaxis and Direction of Cell Migration